Inogen (NASDAQ:INGN) reported Q4 EPS of ($0.57), in-line with the analyst estimate of ($0.57). Revenue for the quarter came in at $88.09 million versus the consensus estimate of $89.49 million.
Inogen (NASDAQ:INGN) reported Q4 EPS of ($0.57), in-line with the analyst estimate of ($0.57). Revenue for the quarter came in at $88.09 million versus the consensus estimate of $89.49 million.